Τόμος 1 (1983) – Τεύχος 2 – Άρθρο 5 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 1 (1983) – Issue 2– Article 5 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Liposomes as drug carriers

Κέντρο Βιολογικών Ερευνών, Εθνικό Ίδρυμα Ερευνών

G.J. Dimitriadis

Biological Research Center, National Hellenic Research foundation, 48 Vas. Constantinou Ave., Athens, Greece

Dimitriadis, G.J.: Liposomes as drug carriers, Epitheorese Klin. Farmakol. Farmakokinet. 2: 125-136 (1983)

Lipososomes, treatment, cells

2.         Bangham, A.D., Hill, M.W and Miller, N.G.A.: Preparation and use of liposomesas models of biological membranes In: Methods in Membrane Biology, Vol. 1,1, Korn, E.D., Ed. Plenum Press, New York (1974)

3.         Gregoriadiv, G.: The carrier potential of liposomes in biology and medicine. N. Engl, J, Med. 295: 765 (1976)

4.         Fendler, J. H. and Romero, A.: Liposomes as drug carriers. Life Sci. 20:1109 Π977)

5.         Kimelberg, H.K. and Mayhew, E.G.: Properties and biological effects of liposomes and their uses in pharmacology and toxicology. Reviews in Toxicology. 10:25 (1978)

6.         Poste, G. Papahadjopoulos, D. and Vail, W.J.: Lipid vesicles as carriers for introducing biologically active materials into cells. In: Methods in Cell Biology, Prescott, D.M., Ed., Vol. 14, 33, Academic Press, New York.

7.         Bangham, A.D.: Lipid bilayers and biomembranes. Anno. Rev. Biochem. 41:753 (1972)

8.         Deamer, D.W. and bangham, A.D.: Large volume liposomes by an ether vaporization method. Biochim Biophys. Acta 443:629 (1976)

9.         Papahadjopoulos, D., Vail, W.J., Jacobson, K. and Poste, G.: Cochleate lipid cylinders fusion of unilamellar lipid vesicles. Biochim. Biophys. Acta 394:483 11975)

10.       Rahman, V.-E., Cerny, E.A., Tollaksen, S.L., Wright, B.J., Nance, S.L., and Thomson, J.F.: Liposome encapsulaled actinomycin D. potential in cancer chemotherapy. Proc. Soc. Exp. Biol. Med. 146:1173 (1974)

11.        Gregoriadis, G.: Drug entrapment in liposomes. FEBS Lett. 36:292 (1973)

12.       Gregoriadis, G., Neerunjum, E.D. and Hunt, R.: Fate of a liposome associated agent injected into normal and tumour-bearing rodents. Attempts to improve localization in tumour tissues. Life Sci. 21:357 (1977)

13.       Weissmen, G., Cohen, L., and Hoffstein, S.: Introduction of enzymes by means of liposomes, into non-phagocytic human cells in vitro. Biochim, Biophys. Acta 493:375 (1977)

14.       Kimelberg, H.K., Lee, C.P., Clande, A., and Mrena, E.: Interactions of cytochrome c with phospholipid membranes I. Binding of cytochrome c to phospholipid liquid crystals. J, Membr. Biol. 2:235 (1970)

15.       Chapman, D., and Wallach, D.F.H.: Recent physical studies of phospholipids and natural membranes, in Biological Membranes, Chapman, D„ Ed., 1, Academic Press, London (1968)

16.       Oldfield, E., and Chapman, D.: Dynamics of lipids in membranes heterogeneity and the role of cholesterol. FEBS, Lett. 23:285 (1972).

17.       Papahadjopoulos, D. Jacobson, K„ Nir., S., and Isac., T.: Phase transitions in phospholibid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol. Biochim. Biophys. Acta. 311:330 (1973)

18.       Ladbrooke, B.D., Williams, R.M. and Chapma, D., Studies on lecithin-cholesteroi-waterinteractions by differential scanning calorimetry and x-ray diffraction. Biochim. Biophys. Acta 150:33 (1968)

19.       Papahadjopoulos, D., Nir, S., and Ohki, S.: Permeability properties of phospholipid membranes effect of cholesterol and temperature. Biochim. Biophys. Acta 266:561 (1971)

20.      Papahadjopoulos, D., Cowden, M., and Kimelberg, H.K., Role of cholesterol in membranes. Effects on phospholipidprotein interactions, membrane permeability and enzyme activity. Biochim. Biophys. Acta 530:8 (1973)

21.       Segal, A.W., Gregoriadis, G. and Black. C.D.V.: Liposome as vehicles for the local release of drugs. Clin. Sci. Mot. Med. 19:99 (1975)

22.       Jonah, M.M., E.A., and Rahman, Y.E.: Tissue distribution of EDTA encapsulated within liposomes of varying surface properties. Biochim. Biophys. Acta 401:336 (1975)

23.       Juliano, R.L. and Stamp, D.: The effect of particle size and sharge on the clearance rates of liposomes and liposome encapsulated drugs. Biochem. Biophys. Res. Common. 63:651 (1975)

24.       Kimelberg, H.K.: Differential distribution of liposome-entrapped (3H) methotrexate and labelled lipids after Intravenous injection in a primate. Biochim. Biophys. Acta 448:531 (1976)

25.       Gregoriadis, G., and Neerunjun, E.D.: Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected into rats. Possible therapeutic applications. Eur. J. Biochem. 47:179 (1974)

26.       Black, C.D.V. and Gregoriadis, G.: Interaction of liposomes with blood plasma proteins. Biochem. Soc. Trans 4:253 (1976)

27.       Magee, W.E., Goft, C.W., Schoknecht, J., Smith, M.D., and Cherian, K.: The interaction of cationic liposomes containing entrapped horseradish peroxidase with cells in culture. J. Cell. Biol. 63:492 (1974)

28.      Papahadjopoulos, D., Poste, G., and Mayhew, E.: Cellular uptake of cyclic AMP captured within phospholidid vesicles and effect on celigrowth behavior. Biochim. Biophys. Acta 363:404 (1974)

29.       Poste, G., and Papahadjopoulos, D.: Lipid vesicles as carriers for introducing materials into cultured cells: influence of vesicle lipid composition on mechanism (s) of vesicle incorporation into cells. Proc. Natl. Acad. Sci. U.SA. 73:1603 (1976)

30.      Papahadjopoulos, D., Poste, G., and Schaffer, B.E.: Fusion of mammalian cells by unilamellar lipid vesicles: influence of iipid surface charge, fluidity and cholesterol, Biochim. Biophys, Acta 323:23 (1973)

31.       Batzri, S., and Korn, E.D.: Interaction of phospholipid vesicles whith cells. Endocytosis and fusion as alternate mechanisms for the uptake of lipid-soluble and water soluble molecules. J. Cell Biot. 66:621 (1975)

32.       Grant, C., and McConnell, H.: Fusion of phospholipid vesicles with viable Achofepfasma iaidiawii. Proc. Nad. Acad. Sci., U.SA. 70:1238 (1973)

33.       Martin, FJ., and MacDonald, R.C.: Lipid vesicle-cell, interactions. I. Hemagglu tination and hemolysis. J. Cell. Biot. 70:494 (1976)

34.       Martin, F.J. and MacDonald, R.C.: Lipid vesicle-cell interactions II Induction of cell fussion. J. Celt Biol. 70:506 (1976)

35.       Martin, F.J., and MacDonald, R.C.: Lipid vesicle-cell interactions III. Introduction of a new antigenic determinant into erythrocyte membranes, J. Ceil. Biol. 70:515 (1976)

36.       Pagano, R.E., and Huang, L.: Interaction of phospholipid vesicles with cultured mammaliam cells. J. Cell. Bioi. 67:49 (1975)

37.       Dimitriadis, G.J.: Cellular uptake of ribonucleic acids entrapped into liposomes. Ceil Biology int. Rep. 3:543 (1979)

38. Bruni, A.,Toffano, G., Leon, A., and Boarato, E.: Pharmacological effects of phosphatidyl serine liposomes. Nature (London} 260:311 (1976)

39.       Chen, J.S., Del Fa, A., Di Luzio, A., and Calissano, P.: Liposome-induced morphological differentiation of murine neuroblastoma. Nature (London) 263:604 (1976)

40.      Patel, H.M., and Ryman, B.E.: The gastrointestinal absorption of liposomally entrapped insulin in normal rats. Biochem. Soc. Trans 5:1054 (1977)

41.       Adams, D.H. Joyce, G. Richardson, V.J., Ryman, B.E., and Wisniewski, H.M.: Liposome toxicity in the mouse central nervous system. J. Neurol. Sci. 31:173 (1977)

42.       Kimelberg, H.K., Tracy, T.F., Watson, R.E., Kung, D., Reis, F.L, and Bourke, R.S.: Distribution of free and liposome-entrapped 3HMTX in the central nervous system after intracerebroventricular injection in a primate. Cancer Res. 38:706 (1978)

43.       Steger, L.D., and Desnick, R.J.: En zyme Therapy. VI. Comparative in vivo fates and effects on lysosomal integrity of enzyme entrapped in negatively and positively charged liposome. Biochim. Biophys. Acta 464:530 (1977)

44.       Schaeffer, B.E., and Curtiv, A.S.G.: Effects on cell adhesion and membrane fluidity of changes in plasmalemmal lipids in mouse L929 cells. J. Cell Sci. 26:47 (1977)

45.       Rahman, Y-E, Rosenthal, M.W. and Cerny E.A.: Intracellular plutonium: romoval by liposome-encapsulated chelating agent. Science 180:300 (1973)

46.       Rahman, Y-E., Rosenthal, M.W., Cerny, E.A., and Moretti, E.S.: Preparation and prolonged tissue retention of liposome-encapsulated chelating agents. J. Lad. din. Med, 63:640 (1974)

47.       Rahman, Y-E, and Wright, B J.: Liposomes containing chelating agents. Cellular penetration and a possible mechanism of metal removal. J. Cell Bioi. 66:112 (1975)

48.      Gregoriadis, G. and Ryman, Β.Ε.: Fate of protein-containing liposomes injected in to rats. An approach to the treatment of storage diseases. Eur. J. Biochem. 24:485 (1972)

49.       Gregoriadis, G., and Ryman, B.E.: Lysosomal localization of B-fructofuranosidase-Containing liposomes injected into rats: some implication in the treatment of genetic disorders. Biochem. J. 129:123 (1972)

50.       Gregoriadis, G., and Buckland, R.A.: Enzyme-containing liposomes alleviate a model for storage disease. Nature (London¡ 244:170 (1973)

51.       Colley, C.M., and Ryman, B.E.: The use of a liposally entrapped enzyme in the treatment of an artificial storage condition, Biochim. Biophys. Acta 457:417 (1976)

52.       Cohen, C.M., Weissmann, G., Hoffstein, S., Awasthi, Y., and Srivastava, S.K.: Introduction of purified hexosaminidase A into Tay-Sachs leukocytes by means of immunoglobulin-coated liposomes. Biochemistry 15:452 (1976)

53.       Ryman, B.E., Jewkers, R.S., Jeyasingh, K., Osborne, M.P., Patel, H.M., Richardson, V.J., Tattersall, M.H.N., and Tyrrell, D.A.: Potential applications of liposomes to therapy. Ann. N.Y. Acad. Sci. 308:281 (1978)

54.       Gregoriadis, G., and Neerunjun, E.D.: Treatment of tumour bearing mice with liposome-entrapped actinomycin D prolongs their survival. Rec. Commun. Chem. Path. Pharmacol. 70:351 (1975)

55.       Rahman, Y-E., Hanson, W.R., Bharucha, J. Ainsworth, EJ. and Jaroslow, B.: Mechanisms of reduction of antitumor drug toxicity by liposome encapsulation.’Ann. N.Y. Acad. Sci. 308:325 (1978)

56.       Kobayashi, T. Tsukagoshi, S., and Sakurai, Y.: Enhancement of the cancer chemotherapeutic effect of cytosine anabinoside entrapped in liposomes on mouse leukemia L-1210. Cann. 66:179 (1975)

57.       Mayhew, E„ Papahadjopoulos, D., Rustum, Y.M. and Dave, C.: Inhibition of tumor cell growth in vitro and in vivo by Ι-β-D-ara-binofuranosylcytosine entrapped within phospholipid vesicles. Cancer Res. 36:4406 (1976)

58.       Mayhew, E. Papahadjopoulos, D. Rustum, Y„ and Dave, C.: Use of liposomes for the enhancement of cytoxic effects of cytosime arabinoside (ARA-C) ανό ιτσ τριπηοσττηοτε (ARA-CTPJ Ann. N.Y. Acad. Sci. 308:371 (1978)

59.       Rustum, Y., Dave, C., Mayhew, E., and Papahadjopoulos, D.: Differential anti-tumor activity of free versus lipid vesicle entrapped cytosine anrabinoside (ARA-C) against mouse leukemia L1210. Ann, N.Y. Acad. Sci. 308:436 (1978)

60.      Colley, C.M., and Ryman, B.E.: Liposomes as carriers in vivo for methotrexate. Biochem. Soc. Trans. 3:157 (1975)

61.       Kimelberg, H.K., and Atchison, M.A.: Effects of entrapment in liposomes on the distribution, degradation and effectivenness of methotrexate in vivo. Ann. N.Y. Acad. Sci. 308:395 (1978)

62.       Tyrrell, D.A., Heath, T.D., Colley, C.M., and Ryman, B.E.: New aspects of liposomes. Biochim. Biophys. Acta 457:259(1976)

63.       Fendler, J.H., and Romero, A.: Encapsulation of 8-azaguanine in single multiple compartment liposomes. Life Sci. 78:1453 (1976)

64.       Dimitriadis, G,J., and Butters, T.: Liposome mediated rictn toxicity in ricin-resistant cells. FEBS Letters 98:33 (1979)

65.       Papahadjopoulos D.: Cholesterol and cell membrane function: a hypothesis concerning the etiology of atherosclerosis, J. Theor. Biol. 43:329 (1974)

66.       Pagano, R.E., and Huang L: Interaction of phospholipid vesicles with cultured mammalin cells. J, Ceil. Biol. 67:49 (1975)

67.       Cooper, R.A., Arner, E.C., Wiley, J.S., and Shattil, S.J.: Modification of red cell membrane structure by cholesterol-rich lipid dispersions. J. Clin. Invest. 55:115

(1975)

68.      Marx, J.L.: Atherosclerosis: the cholesterol connection. Science 794:711 (1976)

69.       Bruckdorfer, K.R., Graham, J.M., and Green, C.: The incorporation of steroid molecules into” lecithin sols, β-lipoproteins and cellular membranes. Eur. J. Biochem 4:512 (1968)

70.       Shaw, I.K., Knight, C.G., and Dingle, J.T.: Liposomal retention of a modified anti-inflammatory steroid. Biochem. J. 758:473 (1976)

71.       Shaw, L.H., Dingle, J.T., Phillips, N.C., Page-Thomas, D.P., and Knight, C.G.: Liposomes in the treatment of experimental arthritis. Ann, N.Y. Acad. Sci. 308:435 (1978)

72.       Carter, W.A., and DeClerq, E.: Viral infection and host defence. Science 186: 1172 (1974).

73.       Straub, S.X., Garry, R.F., and Magee, W.E.: Interferon induction by poly (I): poly (c) enclosed in phospholipid particles. Infect. Immun. 10: 783 (1974).

74.       Magee, W.E., Talcott, M.L., Straub, S.X. and Uriend, C.Y.: A. comparison of negatively and positively charged liposomes containing entrapped polynosinic polycytidylic acid for interferon induction in mice., Biochim. Biophys. Acta 451: 610 (1976).

75.       Dimitriadis, G.J.: Entrapment of ribonucleic acids in liposomes. FEBS Letters 86: 289 (1978).

76.       Dimitriadis, G.J.: Introduction of ribonucleic acids into cells by means of liposomes. Nuct. Acids. Res. 5: 1381 (1978).

77.       Fraley, R.T., Dellaporta, S.L., and Papahadjopoulos, D.: Liposomemediated delivery of tobacco mosaic virus RNA into tobacco protoplast: A sensitive assay for monitoring liposome-protoplast interactions. Proc. Natl. Acad. Sci. U.SA. 79: 1859 (1982).

78.       Dimitriadis, G.J.: Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes. Nature (Londonj 274: 923 (1978).

79.       Wilson, T., Papahadjopoulos, D., and Taber, R.: Biological properties of poliovirus encapsulated in lipid vesicles: antibody resistance and infectivity in virus-resistant cells. Proc. Nati. Acad. Sci. U.SA. 74: 3471 (1977).

80.      Dimitriadis, G.J.: Ebtrapment of plasmid DNA in liposomes. NucL Acids Res. 6: 2697 (1979).

81.       Dimitriadis, G.J.: Transformation of eucaryotrc cells. In Liposome Letters (Ed. Bangham. A.D.), Academic Press, London, 1983.

82.      Nikolau, C., and Rottem, S.: Expression of a b-lactamase activity in mycoplasma capricolum transfected with the liposome encapsulated E. coli pBR 322 plasmid. Biochem. Biophys. Res. Commun 108: 982 11982).

83.      Nikolau, C., Le Pape, A., Soriano, P., Fargette, F., and Juhel, M.F.: In vivo expression of rat insulin following after intravenous administration of liposome-entraped gene for rat insulin I. Proc. Natl. Acad. Sci. (J.SA. 80: 785 (1983).

84.      Magee, W.E. and Miller, O.V.: Liposomes containing antiviral antibody can protect cells from virus infection. Nature (London) 235: 339 (1972).

85.       Gregoriadis, G-, Swain, C.P., Wills, EJ. and Taviil, A.S.: Carrier potential of liposomes in cancer chemotherapy. Lancet 1: 1313 (1974).

86.      Segal, A.W., Gregoriadis, G., Lavender, J.P.: Tarin, D., and Peters, T.J.; Tissue and hepatic subcellular distribution of liposomes containing pleomycin after intravenous administration to patients with neoplasms. Clin. Sci. Mol. Med. 51: 421 (1976).

87.       Alving, C.R., Steck, E.A., Hanson, W.L, Loizeaux, P.S., Chapman, W.L., Jr., and Waits, J.B.: Improved therary of experimental leishmaniasis by use of a liposome encapsulated antimonial drug. Life Sci. 22: 1021 (1978).

88.      New, R.R.C., Chance, M.L, Thomas, S.C., and Peters, W.: Antileishmanial activity of antimonials entrapped in liposomes. Nature (London) 272: 55. (1978).

89.      New, R.R.C., Change, M.L., and Heath, S.: The treatment of experimental cutaneous leishmaniasis with liposome entrapped Pentostam. Parasitology, 83: 519 (1981).

90.      Abra, R.M., Bosworth, M.E., and Hunt, C.A.: Liposome disposition in vivo: effects of pre-dosing with liposomes. Res. Comm, pathof. Pharmacol. 29: 349 (1982).

91.       Abra, R.M. and Hunt, C.A.: Liposome disposition in vivo. IV. The interaction of sequential doses of liposomes having different diameters. Res. Comm. Pathoi. Pharmacol. 36: 17 (1982).

92.       Freise, J., Muller, W.H., and Magerstedt, P.: Uptake of liposomes and sheep red blood cells by the liver and spleen of rats with normal or de creased function of the reticuloendothelial system. Exp. Med. 178: 263 (1981).

93.       Ellens, H. Mayhew, E., and Rustum, Y.M.: Reversible depression of the reticuloendothelial system by liposomes. Biochim. Biophys. Acta 714: 479.

94.       Kao, YJ., and Juliano, R.L.: Interactions of liposomes with the reticuloendothelial system. Effects of rediculoendotheiiai blockade on the clearance of large unilamellar vesicles. Biochim. Biophys, Acta 677:453 (1981).

95.       Souhami, R.L., Patel, H.M., and Ryman, B.E.: The effect ‘of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes. Biochim. Biophys Acta 674: 354 (1981).

96.       Poste, G., Liposome targeting in Vivo. Problems and opportunities. Biol. Cell. 47: 19 (1983).

97.       Weissmann, G., Bloomgarden, D., Kaplan, R., Cohen, Hoffstein, S. Collins, T., Gottlied, A. and Nagle, D.: A general method for the introduction of enzymes, by means of immunoglobulin – coated liposomes, into liposomes of deficient cells. Proc. Natl. Acad. Sci. U.SA. 72: 88 (1975).

98.      Gregoriadis, G., and Neerunjun, E.D., Homing of liposomes to target cells. Biochem. Biophys. Res. Comm. 65: 537 (1975).

99.       Leserman, L.D., Barbet, J., Kourilsky, F.M., and Weinstein, J.N.: Liposomes covalently coupled with monoclonal antibody of Protein. A. Nature 289: 602 (1980).

100.    Martin, F.T., Hubbell, W.L., and Papahadjopoulos D.: Immunospecific targeting of liposomes to cells: A novel and efficient method for covalent attachment of Fab fragments via disulfide bonds. Biochemistry 20: 4229 (1981).

101.     Leserman, L.D., Machy, P., Devaux, C., and Barbet, J.: Antibody-bearing liposomes: Targeting in vivo. Biol. Cei. 47: 111 (1983).

102.     Poste, G.; Bucana, C, Raz, A., Bugelski, P., and Fidler, I.Z., Analysis of the fate of systemically administered liposomes and implications for their use In drug delivery. Cancer Res. 42: 1412 (1982).

103.     Filder. IJ., Raz, A., Fogler, W.E., Kirsh, R., Bulgeski, P., and Poste, G., Design of liposomes to improne delivery of macrophage – augmeting agents, to alveolar macrophages. Cancer Res. 40: 4460 (1980).

104.     Poste, G., Kirsh, R , Raz, A., Soné, S., Bucana, C., Fogler, W.E., and Filder, I J.: Activation of tumoricidal properties in macrophages by liposome encapsulated lymphokines in vitro studies. In «Liposomes in Immunobiolocy» (Tom, B., and Six, H., eds), Elseiver, Amsterdam, 93, (1980).

105.     Filder, I.J., and Poste, G.: Functional activity of macrophages in vivo: destruction of micrometastases. In: Manual of Macrophage Methodology. (Hersco’witz, H.B. Halden, H.T., Bellanti, J.A., and Ghaffer, Eds.), Marke Dekker, New York, 431, (1981).

106.     Filder, I.J., Barnes, Z„ Fogler, W.E., Kirsh, R., Bugelski, P., and Poste, G.: Involvement of Macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators. Cancer Res. 42: 496 (1982).

107.     Fountain, M.W., Dees, C„ and Schultz, R.D,: Enhanced intracellular killing of Staphylococcus aureus by canine monocytes treated with liposomes containing amikacin, gentamicin, kanamycin and tobramucin, Current Microbiol. 6: 373 (1981).